How can we bring hope and health to more patients by turning innovative research into medicines for the world's most challenging diseases? Protheragen Inc. was created to solve this problem. Because actions speak louder than words, we have decided to join force for the translational medicine by connecting bench to bedside. Recently founded, Protheragen grows quickly with the help of many scientists in the company. We value virtues and talented researchers, so we love projects that came up by teams with good character. By placing people at the center of each project, Protheragen pursues a flexible and unique business concept that revolves around the research needs of the researchers. Protheragen serves as an incubator for many early stage drug development programs towards commercialization. Along the way, we also help bridging investments and life-changing innovations.


● AI & Medicine

We have proudly developed a unique artificial intelligence drug research and development platform to offer drug development solutions for worldwide customers. Through big data analysis and other technical means, our AI platform can quickly and accurately mine and select the appropriate compounds or organisms. Compared with traditional methods, AI can save the cost of screening candidates by tens of billions every year. AI technology has been widely used in disease target prediction, high-throughput data analysis and system biology modeling.

Our business is mainly for the medical institutions and pharmaceutical enterprises. Protheragen is dedicated to collaborating with our clients around the world to meet your specific requirements. We have comprehensive capacity and capabilities to provide a broad and integrated portfolio of medical and scientific solutions.

  • 2200 Smithtown Avenue, Room 1, Ronkonkoma, NY 11779-7329, USA
  • Phone: 1-516-666-0889
  • Fax: 1-516-927-0118
  • Email: inquiry@protheragen.com


Copyright © 2005-2020 [ Protheragen ] All Rights Reserved.